Gabapentin Capsule
Product Images NDC 60760-740

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 60760-740). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gaba (Gabapentin 60760 740 90)

Gaba (Gabapentin 60760 740 90)
This text is related to a medication called Gabapentin. The medication is in the form of capsules and is available in different dosages such as 100mg. The medication is manufactured by ScieGen Pharmaceuticals Inc located in Hauppauge, NY 11788. The text provides details like NDC number, lot number, RX number, and expiry date. It also instructs to use the medication as directed and store it at controlled room temperature.*
FDA Label Image

Figure 1 (Image 01)

Figure 1 (Image 01)
This appears to be a data table showing mean pain scores and dosage titration periods for two different treatments, placebo and gabapentin, over several weeks. Not enough context is given to determine the specific study or condition being treated.*
FDA Label Image

Figure 2 (Image 02)

Figure 2 (Image 02)
The text describes a graph showing the mean pain score over a 7-week fixed dose period, where the study participants were given either a placebo or Gabapentin (at either 1800mg/day or 2400mg/day) for their pain. The X-axis represents the weeks, and the Y-axis shows the pain score.*
FDA Label Image

Figure 3 (Image 03)

FDA Label Image

Cockcroft And Gault Equation (Image 04)

FDA Label Image

Gabapentin Structural Formula (Image 05)

FDA Label Image

Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥12 Years Of Age With Partial Seizures (Image 09)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.